Active Arthritis Studies

We are constantly seeking participants for a number of studies. Please apply to any studies for which you may qualify, or call us at (417) 883-7889 for more information!

If You Suffer from Arthritis, Clinvest Is Here to Help

Aching fingers, painful knees, and overall joint stiffness can lock up your lifestyle. Join a Clinvest Research study to help advance medical knowledge of an array of arthritic conditions including Rheumatoid Arthritis, Psoriatic Arthritis, Giant Cell Arteritis, and Ankylosing Spondylitis.

Clinvest knows how challenging and frustrating arthritis difficulties can be. We have a strong commitment to further treatment through specialized research studies including: Rheumatoid, Psoriatic, Giant Cell Arteritis, and Ankylosing Spondylitis. We partner with pharmaceutical companies in an effort to discover solutions for such debilitating conditions and look forward to the new horizons in health and well-being.

    Axial Spondyloarthritis Research Study


    The purpose of this research study is to evaluate the effectiveness and safety of the investigational drug vs placebo to reduce the signs and symptoms in adults with Axial Spondyloarthritis who have had an inadequate response to bDMARD-IR or with active non-radiologic Axial Spondyloarthritis. The study consists of 18 vists. At the completion of the 14-week or 52-week double-blind treatment period, subjects may be entered into a 90-week or 52-week open-label extension period with a total duration of up to 112 weeks (2 years) which will vary depending on qualifications. The investigational drug and all research study-related procedures, including MRI, X-Rays, labs and EKG’s, are provided to eligible participants at no cost. If you qualify to participate, compensation may be provided for your time and travel, which could be up to $125 per study visit.

    Duration: up to 2 years

    Number: 18 visits or more

    Giant Cell Arteritis Study

    Abbvie M16-852

    Eligible subjects over 50 years in age who have been newly diagnosed or have relapsing Giant Cell Arteritis. Participants will be randomized to receive either standard of care or investigational product in addition to standard of care for up to two years over 21 visits. Your first appointment would last approximately 2 hours. If you qualify and choose to volunteer, we would provide investigational study pills, or standard of care pills and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). Compensation may be provided for your time and travel.

    Duration: Up to 2 Years

    Number: 21

Want to find out when new studies are available?

Fill out the form!